Reference Guide for the Nonclinical Toxicity Studies of Antivial Drugs Indicated for the Treatment of N/A Non-Life Threatening Disease Evaluation of Drug Toxicity Prior to Phase I Clinical Studies
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 2, 1998
February 1, 2021
6475f25d-20b3-4aab-b36a-be14f539fc3b
Related Documents
Study of Drugs Likely to be used in the Elderly
Guidance DocumentNovember 1, 1989Center for Drug Evaluation and Research
Preparation of Investigational New Drug Products (Human and Animal): Guidance for Industry
Guidance DocumentNovember 1, 1992Center for Drug Evaluation and Research
Format and Content of the Nonclinical Pharmacology/Toxicology Section of an Application*: Guidance for Industry
Guidance DocumentFebruary 1, 1987Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox